Glycosylation Gene Signatures as Prognostic Biomarkers in Glioblastoma
Glycosylation-related gene expression contributes to GBM heterogeneity and is a valuable biomarker for prognosis and treatment stratification. This study provides insights into personalized treatment approaches for GBM based on glycosylation-related molecular subtypes.
Authors
- Xiyue Wu
- Tong Zhao (ORCID: https://orcid.org/0009-0007-6734-3621)
- Hongliang Ge (ORCID: https://orcid.org/0000-0001-5499-6710)
- Jianwu Chen (ORCID: https://orcid.org/0000-0002-5420-889X)
- Chenchao Lin
Institutions
- Fujian Medical University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1002/acn3.70068
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fujian Provincial Health Commission